Paraquat, a widely used herbicide, has caused hundreds of fatalities from pulmonary fibrosis in patients who have ingested as little as a mouthful of the concentrated solution that is marketed commercially. Many antidotes proposed as therapeutic modalities have failed to alter the course and clinical management rests largely on intensive supportive care. However, one therapeutic modality recently employed but not tested adequately in controlled human studies is that of repeated daily hemoperfusion done until paraquat has been removed from the body. Its efficacy probably depends on its removing paraquat from the body and keeping plasma concentration of the compound below those that allow active uptake of paraquat by the pneumocytes leading to their ultimate destruction and replacement by fibrous tissue. This research plan has been designed to determine under controlled conditions whether or not repeated charcoal hemoperfusion alters the course of paraquat toxicity in the Beagle. Clinical signs of pulmonary toxicity will be evaluated as well as laboratory test manifestations and changes on post-mortem examination in pulmonary, renal, hepatic and cerebral function and structure. Complications of hemoperfusion will be assessed and the cost benefit of the procedure in paraquat poisoning determined. In the second set of experiments, a novel approach to the rapid removal of large amounts of paraquat from paraquat-poisoned mice will be developed and tested. This will be effected by producing murine hybridomas that produce monoclonal antibodies of high specificity and affinity for paraquat. These antibodies will be reduced in size by papain digestion to produce Fab fragments which can be eliminated by the kidney. The efficacy of the antiparaquat Fab fragments in preventing lethality or the pulmonary fibrosis, and on paraquat tissue distribution will be determined in mice given a lethal intravenous injection of paraquat. The ultimate significance of this research extends beyond examination of the ability of these two techniques to remove paraquat from the body to many other intoxicants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003803-02
Application #
3251511
Study Section
Toxicology Study Section (TOX)
Project Start
1985-05-01
Project End
1988-04-30
Budget Start
1986-05-01
Budget End
1987-04-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Queensland University of Technology
Department
Type
DUNS #
City
Brisbane
State
Country
Australia
Zip Code
4001
Winzor, D J; Bowles, M R; Pentel, P R et al. (1991) Adaptation of the Muller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay. Mol Immunol 28:995-1001
Hampson, E C; Effeney, D J; Pond, S M (1990) Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning. J Pharmacol Exp Ther 254:732-40
Hampson, E C; Eyles, D W; Pond, S M (1989) Effects of paraquat on canine bronchoalveolar lavage fluid. Toxicol Appl Pharmacol 98:206-15
Johnston, S C; Bowles, M; Winzor, D J et al. (1988) Comparison of paraquat-specific murine monoclonal antibodies produced by in vitro and in vivo immunization. Fundam Appl Toxicol 11:261-7
Effeney, D J; Hampson, E C; Pond, S M (1988) Creation of a carotid-jugular fistula for repeated hemoaccess in a canine model. J Pharmacol Methods 19:205-11
Bowles, M; Johnston, S C; Schoof, D D et al. (1988) Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. Int J Immunopharmacol 10:537-45
Hampson, E C; Pond, S M (1988) Ultrastructure of canine lung during the proliferative phase of paraquat toxicity. Br J Exp Pathol 69:57-68
Hampson, E C; Pond, S M (1988) Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients. Med Toxicol Adverse Drug Exp 3:64-71
Hogg, P J; Johnston, S C; Bowles, M R et al. (1987) Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: the binding of paraquat to its elicited mouse monoclonal antibody. Mol Immunol 24:797-801
Pond, S M; Johnston, S C; Schoof, D D et al. (1987) Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient. J Toxicol Clin Toxicol 25:305-16